Nampt: linking NAD biology, metabolism and cancer.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing mechanistic biology without original empirical data
PubMed 19109034 · doi:10.1016/j.tem.2008.10.004
What was done
This is a narrative review summarizing the functional biology of nicotinamide phosphoribosyltransferase (Nampt), an enzyme that converts nicotinamide to nicotinamide mononucleotide (NMN). The authors evaluate its regulatory roles in NAD biosynthesis, sirtuin activation, pancreatic beta-cell insulin secretion, and immunomodulation, along with its potential disease implications.
What was found
The abstract provides a qualitative mechanistic summary and reports no quantitative data or specific numbers. It describes Nampt as a critical NAD biosynthetic enzyme regulating NAD-consuming enzymes such as sirtuins, controlling beta-cell insulin secretion, and functioning as an immunomodulatory cytokine relevant to inflammation, type 2 diabetes, and cancer.
Why it matters
The paper outlines how Nampt functions as a bridge between cellular energy metabolism, sirtuin signaling, and inflammation, highlighting its potential utility as a mechanistic target in metabolic disorders and oncology.
Limits
As a narrative review, it presents no original empirical data, quantitative findings, or systematic literature search methodology. Conclusions are limited to theoretical and mechanistic frameworks based on previously published literature.
Cited by
- contradicts NAMPT converts NMN into NAD in a single enzymatic step, and NAMPT expression increases under cellular stress and caloric restriction.